Regeneron Pharmaceuticals (57) | Collaboration Agreements (4)

Recent Contracts

Fourth Amendment to Amended and Restated License and Collaboration Agreement, dated as of October 6, 2021, by and between the Registrant, Sanofi Biotechnology SAS, and Sanofi (Filed With SEC on February 7, 2022)
First Amendment to Immuno-oncology License and Collaboration Agreement, dated as of October 6, 2021, by and between the Registrant and Sanofi Biotechnology SAS (Filed With SEC on February 7, 2022)
Third Amendment to Amended and Restated License and Collaboration Agreement, dated as of April 5, 2020, and effective as of April 1, 2020, by and between the Registrant, Sanofi... (Filed With SEC on August 5, 2020)
Form of Co-Co Collaboration Agreement (Exhibit B to Master Agreement contained in Exhibit 10.4) (Filed With SEC on August 6, 2019)